UK Suspends Novartis Corporation Drug Prexige on Liver Fears

LONDON, Nov 19 (Reuters) - Britain's Medicines and Healthcare products Regulatory Agency said on Monday it had suspended the licence on Novartis AG's painkiller Prexige due to safety concerns about possible liver damage.